&nbsp;

obsp-12-21.xml

Dec 2021

Document

OBSP-7-12-21.html

Dec 2021

Regimen

GILT

Cancer Type:

Hematologic,

Leukemia - Acute Myeloid (AML)

Intent: Palliative

Funding:

Exceptional Access Program

gilteritinib - Relapsed or Refractory FLT3-mutated acute myeloid leukemia

, Collapse Show fewer tags

Drugs Used:

gilteritinib

... Show more tags

Quick Link(s):

Regimen Monograph

Mar 2022

Regimen

BREN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Intermediate Grade,

Lymphoma - T-cell,

Rare Diseases

Intent: Palliative

Funding:

New Drug Funding Program

Brentuximab Vedotin - Previously Treated Primary Cutaneous Anaplastic Large Cell Lymphoma or Mycosis Fungoides

, Collapse Show fewer tags

Drugs Used:

brentuximab vedotin

... Show more tags

Quick Link(s):

Regimen Monograph

Sep 2024

Guidelines and Advice

Recommendations Report Microwave Ablation and Cryoablation

May 2021

Measuring Ontario’s Small Area Inequalities in Cancer (MOSAIC) Study

Étude sur la mesure des inégalités dans les petites zones de l’Ontario en ce qui concerne le cancer (MOSAIC)

Regimen

SMILE(PEG)

Cancer Type:

Hematologic,

Lymphoma - T-cell

Intent: Curative

Funding:

New Drug Funding Program

Pegaspargase - Extranodal Natural Killer/T-cell Lymphoma

, Collapse Show fewer tags

Drugs Used:

mesna,

Quick Link(s):

Regimen Monograph

Sep 2023

Document

EndometrialCancerDiagnosisPathwayMap.pdf

Dec 2021

Document

EndometrialCancerTreatmentPathwayMap.pdf

Dec 2021

Document

OBSP-4-1-22.xml

Jan 2022

Document